While much is known regarding acute nephrotoxic serum (NTS)-induced glomerular injury, the glomerular dynamics and pathophysiologic mediators of the more relevant chronic autologous phase remain poorly defined. Studies were performed in rats 14 d after injection of rabbit serum (n = 6), NTS in the absence (a = 6), or presence, of a cyclooxygenase inhibitor, ibuprofen (a = 6) or a thromboxane A2 (TxA2) receptor antagonist, L-670,596 (a = 5). A mesangial macrophage/ monocyte infiltrate was noted with equal intensity in all NTStreated rats. Glomerular generation rates of prostaglandin (PG) E2, PGF2., and TxA2 in nephritic kidneys were dramatically increased as compared to controls. 2 wk after NTS, there was an increase in glomerular plasma flow rate (SNPF), attainment of filtration pressure disequilibrium, and augmentation of net transcapillary hydraulic pressure difference (AP). Glomerular filtration rate (GFR), however, was reduced, due to a marked fall in the glomerular capillary ultrafiltration coefficient (Kf). Cyclooxygenase inhibition resulted in normalization of glomerular eicosanoid generation rates, amelioration of proteinuria, afferent vasoconstriction, and normalization of SNPF, AP, Kf, and GFR. Selective antagonism of TxA2 also led to preservation of Kf, but was without effect on SNPF, thereby leading to elevated values for GFR. Thus, in contrast to the pathophysiologic role of arachidonate-lipoxygenase products in the early heterologous phase, PG-mediated vasodilatation and TxA2-induced reductions in Kf and GFR underlie glomerular functional changes during autologous mesangioproliferative glomerulonephritis. (J. Clin. Invest. 1990Invest. . 85:1974Invest. -1982 despite relative preservation of renal plasma flow (RPF)' rate (1, 2). In previous studies, we (3) and others (4-17) have used a rat model of glomerulonephritis, induced by the administration ofrabbit anti-rat glomerular basement membrane (GBM) antibody (nephrotoxic serum [NTS]), to define the mechanisms underlying the reductions in GFR and the alterations in renal vascular tone which characterize glomerular inflammatory injury. Two phases of this disease model are recognized: an early (heterologous) phase, occurring 2-24 h after antibody binding to GBM with subsequent complement activation, neutrophil infiltration, and falls in GFR and RPF; and a more chronic (autologous) phase, observed by 7-14 d (19), characterized by proteinuria, a macrophage/monocyte cellular infiltrate, and proliferation of resident glomerular mesangial cells (18) (19) (20) .
Introduction
Human glomerulonephritis is often associated with moderate to severe reductions in the glomerular filtration rate (GFR) 1 . Abbreviations used in this paper: AP, arterial pressure; CO, cyclooxygenase; FF, filtration fraction; NTS, nephrotoxic serum; PAF, platelet activating factor; RPF, renal plasma flow; SNFF, single nephron filtration fraction; SNPF, single nephron plasma flow; UP, urinary protein excretion.
despite relative preservation of renal plasma flow (RPF)' rate (1, 2) . In previous studies, we (3) and others (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) have used a rat model of glomerulonephritis, induced by the administration ofrabbit anti-rat glomerular basement membrane (GBM) antibody (nephrotoxic serum [NTS] ), to define the mechanisms underlying the reductions in GFR and the alterations in renal vascular tone which characterize glomerular inflammatory injury. Two phases of this disease model are recognized: an early (heterologous) phase, occurring 2-24 h after antibody binding to GBM with subsequent complement activation, neutrophil infiltration, and falls in GFR and RPF; and a more chronic (autologous) phase, observed by [7] [8] [9] [10] [11] [12] [13] [14] d (19) , characterized by proteinuria, a macrophage/monocyte cellular infiltrate, and proliferation of resident glomerular mesangial cells (18) (19) (20) .
Micropuncture studies in the past have focused on the heterologous phase of injury (3-5, 7, 9) or have used the model of "accelerated NTS nephritis", in which rats are preimmunized with rabbit IgG 2-3 d before NTS administration (20) , to evaluate the chronic phase (13) (14) (15) . Physiologic and biochemical measurements obtained during accelerated NTS nephritis, however, are conflicting and difficult to interpret (13) (14) (15) due to the marked heterogeneity of glomerular lesions (18) . The histopathologic and functional characteristics of the autologous phase of nonaccelerated NTS nephritis are relatively homogeneous (18) (19) (20) and constitute a more faithful representation oftheir respective counterparts in mild to moderate forms of human glomerulonephritis (1, 2) . Little is known, however, regarding the mediators of injury, and no data is available on glomerular dynamics, in this more relevant phase of the disease.
The present studies examine the role of endogenously generated bioactive lipids in mediating glomerular dysfunction during autologous NTS-induced nephritis. We used micropuncture techniques in the presence and absence of cyclooxygenase (CO) inhibition or thromboxane A2(TxA2)/prostaglandin (PG) endoperoxide receptor blockade, in combination with measurements ofendogenous glomerular eicosanoid generation rates. In addition to defining the glomerular generation rates and target sites of action of PGs, TxA2, and platelet activating factor (PAF) in this model of injury, our findings may provide insight into the mechanisms underlying the improvement in glomerular function observed after administrationofTxA2antagoniststopatientswithactiveglomerulonephri-tis (2 1).
Methods
Preparation ofanti-GBM serum NTS was produced in rabbits by repeated immunization with basement membrane-rich sediment of rat cortex, as previously described (3) . The dosage of NTS used in final experiments was determined by examining the volume of serum required to induce moderate proteinuria (20-40 mg protein/day) in the first 24 h after intravenous injec-Induction ofNTS and experimental protocols Adult male Munich-Wistar rats weighing 220-270 g were maintained in metabolic cages on a standard rat diet and allowed free access to water and food. After collection of urine for 24 h for the measurement ofbase-line protein excretion, 0.2 ml of NTS or 0.2 ml of nonimmune rabbit serum was administered intravenously and a 24-h urine collection was performed daily over the subsequent 14 d. Micropuncture studies, histologic examinations, glomerular isolation and incubation, and preparation of glomerular supernatants and tissue extracts for bioanalytic assays were performed in the same rats 14 d after the administration of NTS. Rats were divided into four experimental groups as follows.
Group I (n = 6). In this group of rats, 0.2 ml of nonimmune rabbit serum, the vehicle for NTS, was administered intravenously on day zero and the above studies and measurements performed on day 14.
Group II(n = 6). In these animals, 0.2 ml ofNTS was administered intravenously on day zero and the above studies and measurements performed on day 14. Group III (n = 6). These animals received NTS as in group II, but were also treated with ibuprofen (The Upjohn Co., Kalamazoo, MI) (20 mg/kg) intraperitoneally on days 1 1-14 and the above studies and measurements performed on day 14.
Group IV(n = 5). In these rats, NTS was administered as in group 
Analytical
Colloid osmotic pressures of plasma entering and leaving glomerular capillaries were estimated from values for protein concentrations (C) in femoral arterial (CA) and surface efferent arteriolar (CE) blood plasmas. Colloid osmotic pressure (r) was calculated according to previously derived equations (24) . Values for CA, and thus TA, for femoral arterial plasma are taken as representative for values for C and ir for the afferent end of the glomerular capillary network. These estimates of pre-and postglomerular protein concentration permit calculation of single nephron filtration fraction (SNFF), and glomerular capillary ultrafiltration coefficient (Kf), as well as resistance of single afferent (RA) and efferent (RE) arterioles, and initial glomerular capillary plasma flow (SNPF), using equations described in detail elsewhere (24) . The concentrations ofinulin in tubule fluid, plasma and urine were determined by measuring the radioactivity of 3H-inulin in a scintillation counter (Beckman Instruments Inc., Palo Alto, CA). Calculation of values for GFR and SNGFR were performed using conventional formulae. The concentration of para-aminohippurate in urine and plasma was determined according to the method of Smith et al. (25) . Protein concentration in efferent arteriolar and femoral arterial blood plasmas were determined using a fluorometric method developed by Viets et al. (26) .
Immediately after termination of micropuncture measurements, kidneys were perfused in situ with a physiologic buffer (buffer A, see below) and glomeruli were isolated by a modified differential sieving technique for analysis of prostanoid generation (groups I-IV) and platelet activating factor (PAF) content (groups I-III), as detailed below.
In selected animals in each group, kidneys were perfused and then prepared for histologic examination. For evaluation of glomerular pathology, kidneys were fixed in Karnovsky's fixative. 4-6-,um paraffin sections were stained with hematoxylin and eosin (H+E).
Immunohistochemical labeling ofglomeruli
Frozen sections (6 Jim) of kidneys harvested from (1) control animals, (2) nephritic animals (day 14), (3) Glomerular isolation, eicosanoid generation assay, and PAF analysis Glomeruli were isolated by a modification of the differential sieving technique, aimed at optimizing glomerular viability (28) . In brief, the removed kidneys were immediately placed in a physiologic buffer (buffer A) consisting of 105 mM NaCl, 24 mM NaHCO3, 5 mM KC1, 2 mM Na2HPO4, 1 mM MgSO4, 1.5 mM CaCl2, 5 mM glucose, 1 mM L-alanine, 10 mM Hepes, and 0.2% BSA, pH 7.4, which was prebubbled with 95% 02/5% CO2 for 30 min. The cortical tissue was then minced at 4VC and transferred to another beaker containing a solution of 0.3 mg/ml collagenase Sigma, Type I, (Sigma Chemical Co., St.
Louis, MO) in buffer A, and bubbled in this solution with 95% 02/5% CO2 for 45 min at 370C. Differential sieving was then carried out by passing cortical tissue sequentially through 150-and 75-Atm sieves, with warming and gentle centrifugation. The glomerular preparation that was obtained was > 95% pure. The isolated glomeruli were then incubated in buffer A maintained at 370C and 95% 02/5% CO2 for 1 h.
The preparation was then centrifuged and divided into the supernatant and the glomerular pellet. The supernatant was frozen at -70°C for eicosanoid generation assays at a later time, and the glomeruli were extracted for measurement of PAF content as described below. The protein content ofthe pelleted glomeruli was assayed by a colorimetric method.
The amounts of PGE2, PGF2,t, and TxB2, the stable metabolite of TxA2, generated by normal and nephritic glomeruli were determined by radioimmunoassay (New England Nuclear, Boston, MA). This was performed after separation of prostanoid-containing fractions of the glomerular supernatants by subjecting the acidified samples to Sep-Pak C-18 prewashed with water and methanol, followed by elutions with water, ethanol-water (15/85, [vol/vol]), petroleum ether, and finally methyl formate. The final fraction was evaporated with N2 and reconstituted in phosphate-buffered saline (29) .
PAF analysis
Glomerular PAF content was determined by gas chromatography/ mass spectrometry using a recently described method applied to the determination of salivary PAF concentrations by Christman and Blair (30) . Pelleted glomeruli were resuspended in methanol and sonicated for 1 min. The mixture was "spiked" with 10 ng of synthetically prepared deuterated PAF. Lipids were extracted by the method of Bligh and Dyer (31) The derivatized compounds were again localized by comparison to a tritiated standard, eluted from silica, and dissolved in decane. Gas chromatography/mass spectrometry was then performed as described in (30) .
Statistical
Intergroup comparisons were performed by ANOVA. Differences were considered significant at a P value . 0.05. All values are reported as mean±SEM.
Results
Morphologic examination. Light microscopic examination in rabbit serum-treated animals (group I) revealed normal appearing glomeruli (Fig. 1 A) . In animals treated with NTS (group II) light microscopic examination of the 14-d lesion revealed a mesangioproliferative form of glomerulonephritis with enlarged glomeruli, mesangial expansion, and mesangial hypercellularity, with preservation of the glomerular capillary thickness (Fig. 1 B) . These changes were present in all glomeruli examined and the intensity of the mesangial infiltrate was homogeneous. Cyclooxygenase inhibition in NTS-treated rats with ibuprofen (group III) and L-670,596 was not associated with amelioration ofthe mesangial cellular infiltrate (Fig. 1 C) .
Indeed, there appeared to be evidence of exacerbation of the lesion, with many glomeruli evincing diffusely proliferative histology. Labeling of glomerular sections for the macrophage cytoplasmic marker ED-1, revealed that the predominant cell type in the mesangial cellular infiltrate was composed of a macrophage/monocyte population (Fig. 1 D) . Glomerular macrophage labeling in control kidneys equalled 0.3±0.1 macrophages/glomerulus. After 14 d of nephritis, there was marked increase to 7.8±0.5 macrophages/glomerulus. Nephritic animals receiving ibuprofen exhibited no diminution in the monocytic invasion of the glomerulus (9.2±0.7 macrophages/glomerulus), nor did those receiving L-670,596 (11.9±0.5 macrophages/glomerulus).
Micropuncture studies. Mean values for Hct, AP, GFR, RPF, FF, and urinary protein excretion in the four groups of animals are summarized in Table I . No significant differences in Hct were observed among the four groups. The autologous phase of anti-GBM-induced glomerulonephritis (group II) was not associated with significant changes in AP, as compared to normal controls (112±5 vs. 114±5 mmHg, NS). Treatment with ibuprofen in group III rats, however, was associated with an elevated value of AP as compared to both control animals (125±1 vs. 114±5 mmHg in group I; P < 0.01), as well as nonibuprofen-treated glomerulonephritic rats in group II (P < 0.01). No elevation in AP was observed in group IV animals which were treated with the TxA2 receptor antagonist, L-670,596, when compared to control rats (110±5 mmHg; NS vs. group I). AP in group IV animals, however, was significantly less than that observed in ibuprofen-treated group III rats (P < 0.01 vs. group III) (See Table I ).
GFR, as measured by inulin clearance, was mildly, but significantly, depressed in group II animals as compared to group I controls (1.00±0.07 vs. 1.18±0.03 ml/min; P < 0.05). Treatment with ibuprofen in group III was associated with full restoration of GFR (1.16±0.07; P < 0.05 vs. group II and NS vs. group I) despite the continued presence of significant inflammatory reaction on histologic examination (Fig. 1) . Of interest, the values for GFR in L-670,596-pretreated animals in group IV were significantly higher than those obtained in normal, nonnephritic animals (group I) (1.30±0.06 ml/min; P < 0.05 vs. group I and P < 0.01 vs. group II groups I and III rats, see Table I ). Thus, the mean values for filtration fraction (FF) in groups II and IV animals were 0.18±0.01 and 0.21±0.02, respectively, values significantly lower than those ofgroup 1 (0.25±0.01; P < 0.01 vs. group II, P < 0.05 vs. group IV) and group III (0.28±0.01; P < 0.01 vs. group II and IV).
In parallel with these changes in whole-kidney GFR, RPF, and FF, single nephron measurements revealed a fall in SNGFR (Fig. 2) . Hydraulic pressure measurements in glomerular capillaries, proximal tubules, and efferent arterioles revealed a mild, but significant, elevation in the mean value for PGc in group II rats as compared to group I controls (50±1 vs. 47±2 mmHg, P < 0.05). Mean PGc values in groups III and IV were intermediate between those obtained in groups I and II, and not significantly different from either (48±1 and 49±3 mmHg, respectively). The mean values for proximal tubule pressure, PT, was significantly depressed in group II animals, as compared to the other three groups of rats (9±1.0 mmHg in group II, P > 0.01 vs. 13±1 mmHg in group I, 12±1 mmHg in group III, and 13±1 mmHg in group IV, respectively). The combined increase in PGc and decrease in PT observed in group II resulted in appreciably greater values for the mean transcapillary hydraulic pressure difference, AP, in this group ofanimals (42±1 mmHg), as contrasted to groups 1 (35±1 mmHg, P < 0.0005 vs. group II), III (36±1 mmHg; P < 0.01 vs. group II), and IV (37±2 mmHg; P < 0.05 vs. group II) (Fig. 3) (15, 23) .
In the present studies, measurements are performed at a single time point after anti-GBM antibody injection (14 d), under euvolemic conditions, and in the setting of the relative homogeneity of the glomerular lesions afforded by the nonaccelerated model of injury. It was our intention to induce a mild form of injury, similar to that seen in the early-to-moderatelyadvanced forms of human glomerulonephritides. The lesion obtained (Fig. 1) 40 treated rats may represent resident mesangial macrophages (32) , which are known to become activated after immune-mediated injury (33) . Quantitative assessment of the macrophage/monocyte infiltrate revealed no significant differences between groups II, III, and IV. This finding excludes a major role for CO products in mediating leukocyte influx into the glomerulus. While the histologic changes noted at this 2-wk time point may not persist throughout the entire course of the autologous phase, mesangial proliferation is a frequently observed early finding in several forms of human inflammatory glomerular diseases, rendering the present results potentially relevant.
Induction of autologous NTS nephritis in group II rats was not associated with significant alterations in AP or Hct. Of interest, however, CO inhibition in group II animals resulted in values for AP significantly above those obtained in normal controls (group I) or in non-CO inhibited nephritic rats (groups II and IV) ( Table I ). The increase in AP in group III is likely due to the inhibition ofthe enhanced renal generation of vasodilator PGs (PGE2) during the course of chronic glomerulonephritis, resulting in renal vasoconstriction.
Values for GFR in group II NTS-treated rats were moderately, but significantly, depressed as comipared to controls (Table I and Fig. 2 ). In contrast, RPF and single nephron plasma flow rates were higher in glomerulonephritic kidneys than in control animals (Table I and Fig. 2 ), a finding similar to that observed by Stork and Dunn (16) . The relative preservation, or even augmentation, of RPF has also been observed in humans with active glomerulonephritis by Friedman et al.
(2) and Meyers et al. (1) . The mechanism underlying the increase in renal perfusion is the selective relaxation of preglomerular resistance (RA) in group II animals as compared to those in group I (Fig. 4) . This is likely due to the local release of a vasorelaxant CO product of arachidonic acid, as evidenced by the marked increase in RA in group III rats in which NTStreated animals received ibuprofen for the 3 d preceding the experiment (Fig. 4) . A role for PGE2 is suggested by the marked stimulation of its glomerular biosynthesis in group II rats and its effective inhibition in group III (Fig. 6) . Ofinterest, the value for RA in group III animals exceeded not only that obtained in group II, but also that of normal controls (group I). This suggests the presence of potent non-CO-dependent vasoconstrictor influences in glomerulonephritic rats, whose actions are antagonized by locally generated PGE2. The predominant afferent action of these putative mediators argues against the involvement of angiotensin II or peptidoleukotrienes, which exert their constrictor actions predominantly on postglomerular arterioles (34, 35) . These findings attest to the complex nature of the neurohumoral systems which mediate the functional derangements during glomerular inflammation.
The augmentation of net mean transcapillary hydraulic pressure difference, AP, in group II rats was due to a relatively greater reduction in RA as compared to RE (and hence increased PGc), as well as lower values for proximal tubule pressure, PT, observed in group II rats. The near-normal values of PGc and PT in groups III and IV was associated with mean AP values which are not significantly different from controls (group I) (See Fig. 3 ).
Despite the higher value ofsingle nephron plasma flow rate (SNPF) and AP which characterized animals in group II, GFR was reduced (Table I and Fig. 2 ) due to the markedly depressed value of the glomerular capillary ultrafiltration coefficient (Kf) (Fig. 5) . Low Kf values have been implicated in the reduction in GFR in the heterologous phase (3) (4) (5) , as well in studies (6, 13) in which glomerular dynamics were measured between days 2 and 16, and 5 and 15, after administration of antibody. Friedman et al. (2) , in their studies on the determinants of glomerular capillary wall function in patients with lupus nephritis, observed a similar profile of glomerular dynamics (assessed by differential solute clearance measurements coupled with mathematical modeling) in which RPF was preserved, but the filtration fraction was low due to a profound reduction in Kf. In view ofthe relative sparing ofthe glomerular capillary wall, as assessed by histologic examination, in our nephritic animals (Fig. 1) , it is reasonable to assume that the observed reduction in Kf is due to the concerted contractile action ofglomerular mesangial cells resulting in a reduction in the capillary surface area available for filtration (3) . That this fall in Kf is indeed of a functional nature, is further supported by its abrogation in both groups III and IV, in which the local synthesis, or the receptor occupancy, of the potent vasoconstrictor, TxA2, is inhibited. (Fig. 5) . These findings from glomerular micropuncture, the enhanced glomerular TxA2 generation rate in NTS-treated rats (Fig. 6) , and the histologic finding of inflammatory cells restricted to the mesangial region ( Fig. 1 (36) . This TxA2-mediated fall in Kf is abrogated in group III, with resultant preservation ofGFR, and in group IV (Table   I and Fig. 2 ). In the latter, however, and in view of continued afferent vasodilatation and augmented nephron plasma flow rate (Figs. 2 and 4) , single nephron and whole kidney GFR attained values which exceeded those in normal controls (Table I and Fig. 2 ). It should be noted that the preservation of GFR during CO inhibition in-group III rats stands in sharp contrast to the findings of Stork and Dunn in a similar model (16) in which no micropuncture measurements are available, but GFR and RPF fell precipitously after administration of CO inhibitors. As noted earlier, however, those studies were performed under hydropenic conditions which are known to alter glomerular dynamics during NTS-induced injury (13) and under which RPF and GFR are exquisitely sensitive to CO inhibition, due to the elevated endogenous levels of angiotensin 11 (37) .
The generation rates of PGE2, PGF2a, and TxA2 were measured in the supernatants of intact glomeruli without the addition of exogenous arachidonate or artificial stimuli, such as calcium ionophores. Since intracellularly generated PGs and TxA2 are rapidly released to the extracellular milieu (38), the measured generation rates likely reflect differences in in vivo intraglomerular eicosanoid release. As seen in Fig. 6 , glomerulonephritic injury is associated with dramatically enhanced glomerular generation of both vasodilator (PGE2) as well as vasoconstrictor (TxA2 and PGF2a,) CO The percent increase in glomerular eicosanoid generation in our studies (Fig. 6 ) is considerably less than the 15-fold increase observed by Stork and Dunn (16) in a similar experimental model. In those studies, however, glomeruli were incubated in the presence of 5 Ag/ml (-16 AM) of exogenously added arachidonic acid, a condition which alters markedly the rates of eicosanoid generation (28) . In addition, those glomeruli were isolated from kidneys subjected to hydropenic conditions, which are known to stimulate renal prostaglandin synthesis (37, 38) , and measurements were performed using a glomerular isolation technique which has since been demonstrated to contain a significant percentage of cells undergoing anoxic injury (28) , a condition also known to be associated with increased arachidonic acid release (39) .
In view of increasing interest in the glomerular actions and pathophysiologic significance of PAF in models of renal injury, including rabbit NTS nephritis (40) , and in light of our recent demonstration that the glomerular actions of PAF were mediated through the secondary glomerular release of TxA2 (41) , we assessed its generation rates in our experimental animals. Gas chromatography/mass spectrometry is the most reliable method currently available to measure PAF generation in biological samples (42) . No enhancement of PAF biosynthesis was observed in group II rats, and no modification of its baseline synthetic rates was noted in ibuprofen-treated animals in group III (Fig. 7) . It thus appears unlikely that PAF plays a major role in mediating glomerular functional alterations in this model of chronic glomerular inflammation. It remains possible, however, that its extracellular degradation rate (PAF-acetyl hydrolase activity) is altered in nephritic glomeruli as compared to controls. The significant fall in protein excretion in group III, despite normalization of GFR, reflects a true improvement in glomerular sieving function in this group ofanimals. The lack ofa similar improvement in group IV implicates non-TxA2 products ofthe CO pathway in mediating, in part, the alterations in glomerular permselectivity induced by the inflammatory lesion. A role for PGE2 is proposed in this regard in view of the known capacity of this eicosanoid to amplify alterations in vascular permeability in other models of inflammation (43) . Furthermore, it seems unlikely that the improvement in glomerular sieving function in these animals is due to hemodynamic factors (44) . The failure of protein excretion to fall in group IV rats, despite the reduction in AP, would also argue against elevations in this parameter as being of importance in mediating permselectivity changes in accord with the heteroporous membrane model, as recently proposed by Yoshioka et al. (45) . In 
